Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01646840 · ClinicalTrials.gov registry record · Phase 1
Study Of The PF-04958242 Blood Concentrations Of A Capsule Formulation Of PF-04958242 Compared To A Solution Formulation
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01646840 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 12 participants.
The verdict
NCT01646840, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will assess the relative bioavailability of a capsule formulation of PF-04958242, relative to a oral solution formulation of PF-04958242 in healthy adult subjects.
Interventions
- DRUG PF-04958242 capsule
- DRUG PF-04958242 oral solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-07 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01646840
The ClinicalTrials.gov registry entry for NCT01646840 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PF-04958242 capsule is the first listed.
NCT01646840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01646840 about?
NCT01646840 is a clinical study titled "Study Of The PF-04958242 Blood Concentrations Of A Capsule Formulation Of PF-04958242 Compared To A Solution Formulation". This study will assess the relative bioavailability of a capsule formulation of PF-04958242, relative to a oral solution formulation of PF-04958242 in healthy adult subjects.
What is the current status of trial NCT01646840?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2012-07. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01646840?
The interventions under investigation include: PF-04958242 capsule (DRUG), PF-04958242 oral solution (DRUG).
Who is sponsoring clinical trial NCT01646840?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.